FDA Adverse Event Injury Summary report: N

ZEPHYR ENDOBRONCHIAL VALVE

MDR report key: 17933154 · Received October 13, 2023

Report

Report Number
3007797756-2023-00182
Event Type
Injury
Date Received
October 13, 2023
Date of Event
September 13, 2023
Report Date
October 12, 2023
Manufacturer
PULMONX CORPORATION
Product Code
NJK
UDI-DI
00811907030225
PMA / PMN Number
P180002
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

PULMONARY EDEMA IS A RELATED COMPLICATION TO THE ZEPHYR VALVE TREATMENT AND BRONCHOSCOPIC LUNG VOLUME REDUCTION PROCEDURE WITH A VERY LOW INCIDENCE. IN THE LIBERATE STUDY (IDE CLINICAL STUDY USED TO SUPPORT PMA P180002'S APPROVAL), THERE WAS ONE REPORTED EVENT OF PULMONARY EDEMA OUT OF 128 TREATED PATIENTS. THERE HAS BEEN A PRIOR REPORT OF PULMONARY EDEMA IN COMPLAINT HISTORY. THE EVENT ALIGNS WITH THE EXPERIENCE OBSERVED IN THE LIBERATE CLINICAL STUDY AND IS A RELATED, POTENTIAL COMPLICATION TO THE ZEPHYR VALVE TREATMENT WITH A LOW PROBABILITY OF OCCURRENCE.

Description of Event or Problem · 0

THE PATIENT HAD A BRONCHOSCOPIC LUNG VOLUME REDUCTION (BLVR) PROCEDURE WITH FIVE ZEPHYR VALVES PLACED IN THE LEFT UPPER LOBE ON (B)(6) 2023. THE PATIENT HAS A HISTORY OF CONGESTIVE HEART FAILURE. THE DAY AFTER THE BLVR PROCEDURE, THE PATIENT HAD ASYMMETRIC PULMONARY EDEMA WITH INCREASED OXYGEN REQUIREMENTS. THE PATIENT'S BASELINE OXYGEN REQUIREMENT WAS 4 - 8 L, AND IT WAS INCREASED TO 10 L. THE PHYSICIAN REMOVED ALL VALVES ON SEP. 13, 2023. AFTER RESOLUTION, THE PATIENT WAS DISCHARGED FROM THE HOSPITAL ON (B)(6) 2023 ON 7 L OF OXYGEN WITH INSTRUCTIONS TO WEAN AT HOME.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
631659 ZEPHYR ENDOBRONCHIAL VALVE ENDOBRONCHIAL VALVE NJK PULMONX CORPORATION ZEPHYR 4.0-LP EBV 506028-V7.1 00811907030225

Patients

Seq Age Sex Outcome Treatment
1 Female Hospitalization